A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the maintained effectiveness of long-acting
injectable risperidone (RISPERDAL® CONSTA™) compared with the previous treatment with oral
olanzapine in non-acute subjects with schizophrenia or schizoaffective disorder considered in
need of a therapy change.